Lilly’s stock was tumbling as disappointing trial data for an oral weight-loss pill offset an upbeat earnings report and outlook.
Bank of England committee was so divided there were two votes on interest rates
U.K. central bank had to hold two votes after a rare, initial 4-4-1 decision.